Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaveh Zakeri

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Underrepresentation of Local Therapy Trials in Leading Medical Journals: Cause for Outrage or Indifference?Loren K Mell, Kaveh Zakeri
Journal of Surgical Oncology|October 1, 2021
HPV-associated oropharyngeal cancer de-escalation strategies and trials: Past failures and future promiseKaveh Zakeri, Lara Dunn, Nancy Lee
Oncotarget|October 22, 2021
Javelin Head Neck 100: Should we combine immunotherapy with radiation therapy?Yao Yu, Kaveh Zakeri, Nancy Lee
The Lancet. Oncology|November 5, 2020
An imbalance in competing mortality favouring Debio 1143Kaveh Zakeri, Yao Yu, Nancy Lee
Frontiers in Oncology|May 16, 2018
Radiation Oncology in the 21st Century: Prospective Randomized Trials That Changed Practice… or Didn't!Kaveh Zakeri, C Norman Coleman, Bhadrasain Vikram
Advances in Radiation Oncology|July 22, 2022
In Reply to Qureshi et alJennifer Hesse, Kaveh Zakeri, Nancy Y Lee
JAMA Oncology|November 20, 2018
Detecting a Survival Benefit to Dose EscalationKaveh Zakeri, Brent S Rose, Loren K Mell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2014
On lumping, splitting, and the nosology of clinical trial populations and end pointsLoren K Mell, Kaveh Zakeri, Brent S Rose
Trials|June 28, 2021
Public access to protocols of contemporary cancer randomized clinical trialsChristopher Babu, Loren Mell, Nancy Lee, et al.
JAMA Oncology|June 9, 2022
Association of Low and Intermediate Combined Positive Scores With Outcomes of Treatment With Pembrolizumab in Patients With Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma: Secondary Analysis of Keynote 048Yao Yu, Kaveh Zakeri, Eric J Sherman, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Underrepresentation of Local Therapy Trials in Leading Medical Journals: Cause for Outrage or Indifference?Loren K Mell, Kaveh Zakeri
Journal of Surgical Oncology|October 1, 2021
HPV-associated oropharyngeal cancer de-escalation strategies and trials: Past failures and future promiseKaveh Zakeri, Lara Dunn, Nancy Lee
Oncotarget|October 22, 2021
Javelin Head Neck 100: Should we combine immunotherapy with radiation therapy?Yao Yu, Kaveh Zakeri, Nancy Lee
The Lancet. Oncology|November 5, 2020
An imbalance in competing mortality favouring Debio 1143Kaveh Zakeri, Yao Yu, Nancy Lee
Frontiers in Oncology|May 16, 2018
Radiation Oncology in the 21st Century: Prospective Randomized Trials That Changed Practice… or Didn't!Kaveh Zakeri, C Norman Coleman, Bhadrasain Vikram
Advances in Radiation Oncology|July 22, 2022
In Reply to Qureshi et alJennifer Hesse, Kaveh Zakeri, Nancy Y Lee
JAMA Oncology|November 20, 2018
Detecting a Survival Benefit to Dose EscalationKaveh Zakeri, Brent S Rose, Loren K Mell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2014
On lumping, splitting, and the nosology of clinical trial populations and end pointsLoren K Mell, Kaveh Zakeri, Brent S Rose
Trials|June 28, 2021
Public access to protocols of contemporary cancer randomized clinical trialsChristopher Babu, Loren Mell, Nancy Lee, et al.
JAMA Oncology|June 9, 2022
Association of Low and Intermediate Combined Positive Scores With Outcomes of Treatment With Pembrolizumab in Patients With Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma: Secondary Analysis of Keynote 048Yao Yu, Kaveh Zakeri, Eric J Sherman, et al.
Pageof 9